(Q63844799)

English

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

clinical trial

Statements

A 36-Week Safety Extension Study of Oral ELND005 for Treatment of Agitation and Aggression in Patients With Moderate to Severe Alzheimer's Disease (English)
0 references
0 references
0 references
0 references
January 2013
0 references
August 2015
0 references
296
0 references
50 year
0 references
95 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit